Note 4 Derivative Financial Instruments

3 Months Ended

Dec. 29, 2012

Summary of Derivative Instruments [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

. Derivative Financial Instruments

The Company is exposed to certain risks related to its ongoing business operations. The primary risks managed by using derivative instruments are interest rate risk and foreign exchange rate risk.

Interest Rate Risk

Interest rate swaps are used to manage interest rate risk associated with borrowings under the Company's long-term debt arrangements.

Interest Rate Swaps Not Designated As Hedging Instruments

The Company has interest rate swaps with an aggregate notional amount of $257 million that were entered into in 2007 to hedge LIBOR-based variable rate interest payments expected to occur through June 15, 2014. As of December 29, 2012, the Company had $257.4 million of 2014 Notes (LIBOR-based, floating rate debt) outstanding. However, in the first quarter of 2013, the Company called $100.0 million of these notes for redemption (redeemed on January 9, 2013) and, on January 28, 2013, called the remaining $157.4 million for redemption. These redemptions are expected to be funded with a combination of cash on hand and borrowings under the Company's revolving credit facility (LIBOR-based, variable rate facility). Therefore, in the first quarter of 2013, the Company determined it was no longer probable that LIBOR-based, variable rate interest payments would occur on the portion of 2014 Notes expected to be redeemed with cash on hand. Instead, LIBOR-based variable rate payments are only expected to occur on forecasted borrowings under the Company's revolving credit facility and only during the period of time these borrowings are outstanding. Accordingly, the Company dedesignated its interest rate swaps in their entirety in the first quarter of 2013 and recorded a charge of $14.9 million to other expense, net, representing the portion of the value of the interest rate swaps previously recorded in accumulated other comprehensive income for which it is no longer probable that LIBOR-based variable rate interest payments will occur. The remaining AOCI balance as of December 29, 2012 was $3.9 million and is expected to be amortized to interest expense over the next 9 months, representing the period during which borrowings under the revolving credit facility that were used to repay a portion of the 2014 Notes are expected to remain outstanding.

Under the terms of the swap agreements, the Company pays the independent swap counterparties a fixed rate of approximately 5.6% and the swap counterparties pay the Company an interest rate equal to three-month LIBOR. As of December 29, 2012, the fair value of the interest rate swaps was $19.8 million and is included in other long-term liabilities on the condensed consolidated balance sheet. The Company does not intend to liquidate the swap agreements and will therefore continue to make and receive payments under the swaps through June 15, 2014. Beginning on the date the interest rate swaps were dedesignated, changes in the fair value of the interest rate swaps will be recorded to other expense, net, in the condensed consolidated statement of income. Such amount was not material for the first quarter of 2013.

Fair Value Hedge

The Company has $500 million of fixed-rate senior notes (the "2019 Notes") outstanding as of December 29, 2012 and has an interest rate swap with a single counterparty to hedge its exposure to changes in the fair value of the notes resulting from fluctuations in interest rates. The swap agreement, with a notional amount of $500 million and an expiration date of May 15, 2019, effectively converts these notes from fixed-rate debt to variable-rate debt. Pursuant to the interest rate swap, the Company pays the swap counterparty a variable rate equal to the three-month LIBOR plus a spread and receives a fixed rate of 7.0% from the swap counterparty. The swap counterparty has the unilateral right to terminate the swap beginning in 2014, consistent with the Company's ability to call the 2019 Notes beginning in 2014. In accordance with ASC Topic 815, the interest rate swap is accounted for as a fair value hedge and is exempt from periodic assessment of hedge effectiveness. Therefore, the change in the fair value of the 2019 Notes resulting from changes in interest rates is assumed to be equal and opposite to the change in the fair value of the interest rate swap. As of December 29, 2012, the fair value of the interest rate swap was $37.5 million and is included in other non-current assets on the condensed consolidated balance sheet.

Foreign Exchange Rate Risk

Forward contracts on various foreign currencies are used to manage foreign currency risk associated with forecasted foreign currency transactions and certain monetary assets and liabilities denominated in foreign currencies. The Company's primary foreign currency cash flows are in certain Asian and European countries, Israel, Brazil and Mexico.

The Company had the following outstanding foreign currency forward contracts that were entered into to hedge foreign currency exposures:

	As of
	December 29, 2012		September 29, 2012
Derivatives Designated as Accounting Hedges:
Notional amount (in thousands)	$	102,950	$	123,050
Number of contracts	47		49
Derivatives Not Designated as Accounting Hedges:
Notional amount (in thousands)	$	316,588	$	292,469
Number of contracts	43		33

The Company enters into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in foreign currencies. These contracts have maturities of up to two months and are not designated as accounting hedges under ASC Topic 815. Accordingly, these contracts are marked-to-market at the end of each period with unrealized gains and losses recorded in other expense, net, in the condensed consolidated statements of income. For the first quarter of 2013 and 2012, the Company recorded a loss of $2.7 million and a gain of $5.3 million, respectively, associated with these forward contracts. From an economic perspective, gains and losses on forward contracts substantially offset gains and losses on the underlying hedged items for both periods presented herein.

The Company also utilizes foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures generally result from forecasted sales denominated in currencies other than those used to pay for materials and labor. These contracts are up to twelve months in duration and are accounted for as cash flow hedges under ASC Topic 815.

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI), an equity account, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on derivative instruments representing hedge ineffectiveness are recognized in current earnings and were not material in the first quarter of 2012. As of December 29, 2012, AOCI related to foreign currency forward contracts was not material.

The following table presents the effect of cash flow hedging relationships on the Company's condensed consolidated statements of operations:

Derivative Type and Income Statement Location	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)					Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)						Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Ineffective Portion)
	Three Months Ended					Three Months Ended						Three Months Ended
	December 29, 2012		December 31, 2011			December 29, 2012			December 31, 2011			December 29, 2012			December 31, 2011
	(In thousands)
Interest rate swaps - Other expense, net	$	—	$	—		$	—		$	—		$	(14,903	)	$	—
Interest rate swaps - Interest expense	96		73			(3,026		)	(3,313		)	—			—
Foreign currency forward contracts - Cost of sales	159		(1,201		)	4			(951		)	—			—
Total	$	255	$	(1,128	)	$	(3,022	)	$	(4,264	)	$	(14,903	)	$	—